These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 2532713)

  • 1. [3H]tyramine binding: a comparison with neuronal [3H]dopamine uptake and [3H]mazindol binding processes.
    Vaccari A; Gessa G
    Neurochem Res; 1989 Oct; 14(10):949-55. PubMed ID: 2532713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [3H]mazindol binding associated with neuronal dopamine and norepinephrine uptake sites.
    Javitch JA; Blaustein RO; Snyder SH
    Mol Pharmacol; 1984 Jul; 26(1):35-44. PubMed ID: 6087116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential visualization of dopamine and norepinephrine uptake sites in rat brain using [3H]mazindol autoradiography.
    Javitch JA; Strittmatter SM; Snyder SH
    J Neurosci; 1985 Jun; 5(6):1513-21. PubMed ID: 4009243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative effects of amphetamine, phenylethylamine and related drugs on dopamine efflux, dopamine uptake and mazindol binding.
    Parker EM; Cubeddu LX
    J Pharmacol Exp Ther; 1988 Apr; 245(1):199-210. PubMed ID: 3129549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential response of striatal dopamine and muscarinic cholinergic receptor subtypes to the loss of dopamine. I. Effects of intranigral or intracerebroventricular 6-hydroxydopamine lesions of the mesostriatal dopamine system.
    Joyce JN
    Exp Neurol; 1991 Sep; 113(3):261-76. PubMed ID: 1833219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transport of [3H]mazindol binding sites in mesostriatal dopamine axons.
    O'Dell SJ; Marshall JF
    Brain Res; 1988 Sep; 460(2):402-6. PubMed ID: 3147121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High affinity binding of [3H]-tyramine in the central nervous system.
    Vaccari A
    Br J Pharmacol; 1986 Sep; 89(1):15-25. PubMed ID: 3801770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoradiography of dopamine receptors and dopamine uptake sites in the spontaneously hypertensive rat.
    Kujirai K; Przedborski S; Kostic V; Jackson-Lewis V; Fahn S; Cadet JL
    Brain Res Bull; 1990 Nov; 25(5):703-9. PubMed ID: 2149666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [3H]GBR-12935 binding to dopamine uptake sites in rat striatum.
    Allard PO; Eriksson K; Ross SB; Marcusson JO
    Neuropsychobiology; 1990-1991; 23(4):177-81. PubMed ID: 2130286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thermodynamic analyses of the binding of substrates and uptake inhibitors on the neuronal carrier of dopamine labeled with [3H]GBR 12783 or [3H]mazindol.
    Bonnet JJ; Benmansour S; Costentin J; Parker EM; Cubeddu LX
    J Pharmacol Exp Ther; 1990 Jun; 253(3):1206-14. PubMed ID: 2141637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropeptide-dopamine interactions. V. Cyclo(His-Pro) regulation of striatal dopamine transporter complex.
    Ikegami H; Prasad C
    Peptides; 1990; 11(1):145-8. PubMed ID: 2342989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations in striatal and extrastriatal D-1 and D-2 dopamine receptors in the MPTP-treated common marmoset: an autoradiographic study.
    Gnanalingham KK; Smith LA; Hunter AJ; Jenner P; Marsden CD
    Synapse; 1993 Jun; 14(2):184-94. PubMed ID: 8332947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Properties of rat striatal D-2 dopamine receptors solubilized with the zwitterionic detergent CHAPS.
    Kilpatrick GJ; Jenner P; Marsden CD
    J Pharm Pharmacol; 1985 May; 37(5):320-8. PubMed ID: 2862240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of characteristics of dopamine uptake and mazindol binding in mouse striatum.
    Zimányi I; Lajtha A; Reith ME
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Dec; 340(6):626-32. PubMed ID: 2615854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High affinity stereospecific binding of [3H] cocaine in striatum and its relationship to the dopamine transporter.
    Calligaro DO; Eldefrawi ME
    Membr Biochem; 1987-1988; 7(2):87-106. PubMed ID: 3454391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of serotonergic and dopaminergic lesions on sodium-sensitive [3H]mazindol binding in rat hypothalamus and corpus striatum.
    Angel I; Janowsky A; Paul SM
    Brain Res; 1989 Dec; 503(2):339-41. PubMed ID: 2514010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential response of striatal dopamine and muscarinic cholinergic receptor subtypes to the loss of dopamine. II. Effects of 6-hydroxydopamine or colchicine microinjections into the VTA or reserpine treatment.
    Joyce JN
    Exp Neurol; 1991 Sep; 113(3):277-90. PubMed ID: 1833220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Striatal dopamine innervation and receptor density: regional effects of the weaver mutation.
    Pullara JM; Marshall JF
    Brain Res; 1989 Feb; 480(1-2):225-33. PubMed ID: 2653564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine denervation does not alter in vivo 3H-spiperone binding in rat striatum: implications for external imaging of dopamine receptors in Parkinson's disease.
    Bennett JP; Wooten GF
    Ann Neurol; 1986 Apr; 19(4):378-83. PubMed ID: 3707090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [3H]mazindol binding associated with neuronal dopamine uptake sites in corpus striatum membranes.
    Javitch JA; Blaustein RO; Snyder SH
    Eur J Pharmacol; 1983 Jun; 90(4):461-2. PubMed ID: 6884434
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.